These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Biochemical characterization of alpha-ketooxadiazole inhibitors of elastases.
    Author: Wieczorek M, Gyorkos A, Spruce LW, Ettinger A, Ross SE, Kroona HS, Burgos-Lepley CE, Bratton LD, Drennan TS, Garnert DL, Von Burg G, Pilkington CG, Cheronis JC.
    Journal: Arch Biochem Biophys; 1999 Jul 15; 367(2):193-201. PubMed ID: 10395735.
    Abstract:
    A series of alpha-ketooxadiazole compounds was prepared and evaluated in vitro as potential inhibitors of human neutrophil elastase (HNE), proteinase-3 (PR-3), and porcine pancreatic elastase (PPE). Several compounds have been found to be very potent, fast, reversible, and selective inhibitors of HNE with Ki values below 100 pM. The highest kon value exceeded 10(7) M(-1) s(-1). Some alpha-ketooxadiazoles were also very effective against PR-3 and PPE with Ki values in the range of 5(-10) nM and 0.1(-2) nM, respectively. The two rings, 1,2,4- and 1,3,4-oxadiazole, are amenable to substitutions, extending the P' side of the inhibitor and allowing additional binding interactions at S' subsites of the enzyme. Nonpeptidic HNE inhibitors containing the oxadiazole heterocycle displayed promising oral bioavailability.
    [Abstract] [Full Text] [Related] [New Search]